These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 23641007)

  • 21. Vascular reactivity in diabetes mellitus.
    Dandona P
    Endocrinol Nutr; 2009 Dec; 56 Suppl 4():12-4. PubMed ID: 20629223
    [No Abstract]   [Full Text] [Related]  

  • 22. Oxidative stress and diabetic complications.
    Giacco F; Brownlee M
    Circ Res; 2010 Oct; 107(9):1058-70. PubMed ID: 21030723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is insulin resistance atherogenic? Possible mechanisms.
    Defronzo RA
    Atheroscler Suppl; 2006 Aug; 7(4):11-5. PubMed ID: 16815101
    [No Abstract]   [Full Text] [Related]  

  • 24. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Endothelial dysfunction in diabetes].
    Nishio Y
    Nihon Rinsho; 2010 May; 68(5):823-6. PubMed ID: 20446576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes.
    Paneni F; Costantino S; Castello L; Battista R; Capretti G; Chiandotto S; D'Amario D; Scavone G; Villano A; Rustighi A; Crea F; Pitocco D; Lanza G; Volpe M; Del Sal G; Lüscher TF; Cosentino F
    Eur Heart J; 2015 Apr; 36(13):817-28. PubMed ID: 24801072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A lethal tetrad in diabetes: hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction.
    Yu Y; Lyons TJ
    Am J Med Sci; 2005 Nov; 330(5):227-32. PubMed ID: 16284482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pin1 inhibitor Juglone prevents diabetic vascular dysfunction.
    Costantino S; Paneni F; Lüscher TF; Cosentino F
    Int J Cardiol; 2016 Jan; 203():702-7. PubMed ID: 26583846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanism of diabetic macroangiopathy].
    Nishio Y
    Nihon Rinsho; 2006 Nov; 64(11):1991-7. PubMed ID: 17087288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis.
    Nakagami H; Kaneda Y; Ogihara T; Morishita R
    Curr Diabetes Rev; 2005 Feb; 1(1):59-63. PubMed ID: 18220582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of endothelial dysfunction in the development of vascular complications of diabetes].
    Turenkov IN; Voronkov AV; Slietsans AA
    Patol Fiziol Eksp Ter; 2013; (2):80-4. PubMed ID: 24000720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial dysfunction and its role in diabetic vascular disease.
    Hartge MM; Kintscher U; Unger T
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):551-60, viii-ix. PubMed ID: 16959585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial dysfunction in diabetes mellitus.
    Hadi HA; Suwaidi JA
    Vasc Health Risk Manag; 2007; 3(6):853-76. PubMed ID: 18200806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis.
    Förstermann U; Xia N; Li H
    Circ Res; 2017 Feb; 120(4):713-735. PubMed ID: 28209797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial dysfunction in normal and abnormal glucose metabolism.
    Esper RJ; Vilariño JO; Machado RA; Paragano A
    Adv Cardiol; 2008; 45():17-43. PubMed ID: 18230954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.
    Knapp M; Tu X; Wu R
    Acta Pharmacol Sin; 2019 Jan; 40(1):1-8. PubMed ID: 29867137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast growth factor 21 Ameliorates diabetes-induced endothelial dysfunction in mouse aorta via activation of the CaMKK2/AMPKα signaling pathway.
    Ying L; Li N; He Z; Zeng X; Nan Y; Chen J; Miao P; Ying Y; Lin W; Zhao X; Lu L; Chen M; Cen W; Guo T; Li X; Huang Z; Wang Y
    Cell Death Dis; 2019 Sep; 10(9):665. PubMed ID: 31511499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Possible involvement of insulin and oxidative stress in vascular dysfunction of diabetic mellitus].
    Kobayashi T
    Yakugaku Zasshi; 2008 Jul; 128(7):1013-21. PubMed ID: 18591869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.